EBE Annual General Meeting 2016
The EBE Annual General Meeting will take place on 14 June 2016 in Brussels.
Following the statutory part of the meeting (from 16h:00 CET) we are proud to offer to all our members an opportunity for information and debate though our session dedicated to IMI – opportunities and challenges for developing Advanced Therapies (until 19h00). We would like to encourage all interested company delegated to actively participate in this session.
Watch here the live broadcast
CEO TiGenix and incoming EBE President
Global Head Discovery & Investigative Safety and Therapeutic Areas, Novartis Pharma
CEO Ixaltis and the outgoing EBE president (moderator)